Jeremy Fraysse

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Men Who Have Sex With Men

Top Venues

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics 42 (4) (2024)
Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics 42 (4) (2024)
Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics 42 (4) (2024)
Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics 42 (4) (2024)
Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics (2024)